Table 1.
Patient and Tumor Characteristics by Patient Group.
| Unselected (n = 70) | Standard Chemoresponsive (n = 20) | High-Dose Chemoresponsive (n = 11) | Chemorefractory (n = 20) | |
| Median age in years (range) | 33 (15–63) | 32 (17–49) | 27 (21–47) | 28 (16–56) |
| Histology | ||||
| Mixed NS | 43 | 9 | 6 | 9 |
| Embryonal carcinoma | 20 | 3 | 1 | 3 |
| Yolk sac tumor | 1 | 3 | 2 | 7 |
| Mature teratoma | 6 | 5 | 1 | 0 |
| Choriocarcinoma | 0 | 0 | 1 | 1 |
| Treatment | Not applicable | Standard first line | High-dose chemotherapy | Standard first line, high-dose chemotherapy, salvage chemotherapy |
| Median progression-free survival | Not applicable | > 5 years | 129 weeks | 29 weeks, all DOD |